About Company
AHEAD Medicine is a medical technology company dedicated to developing artificial intelligence (AI)-driven cell detection and data analysis platforms. The company is founded by an interdisciplinary team from the Hematology Department of National Taiwan University Hospital and the Department of Electrical Engineering at National Tsing Hua University. By collaborating with top medical centers worldwide, AHEAD Medicine has developed a fully automated flow cytometry data analysis platform. This platform is designed to accelerate the development of vaccines, drugs, and cell therapies, as well as to aid in clinical disease diagnosis and monitoring.
Product Name
Cyto-Copilot
AHEAD Medicine’s product, Cyto-Copilot, aims to assist clinicians in overcoming challenges in interpreting test results and making clinical decisions. By leveraging AI technology, it provides next-generation support tools that enable physicians to conduct rapid, objective, and comprehensive analyses. These tools help alleviate the burden on medical personnel, reduce delays in patient treatment, enhance therapeutic outcomes for leukemia patients, lower healthcare costs, and increase the service capacity of core laboratories in medical centers.
Product Info
Cyto-Copilot is am AI-driven solution for flow cytometry automatic data analysis, aiming to assist clinicians in overcoming challenges in interpreting test results and making clinical decisions. By leveraging AI technology, it provides next-generation support tools that enable physicians to conduct rapid, objective, and comprehensive analyses. These tools help alleviate the burden on medical personnel, reduce delays in patient treatment, enhance therapeutic outcomes for leukemia patients, lower healthcare costs, and increase the service capacity of core laboratories in medical centers.
Get in touch directly with us.
+886-2-7756-1768
6F., No. 26, Sec. 3, Nanjing E. Rd., Zhongshan Dist., Taipei City 104103 , Taiwan